These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38443618)

  • 1. SARS-CoV-2 infection prevalence and associated factors among primary healthcare workers in France after the third COVID-19 wave.
    Pouquet M; Decarreaux D; Di Domenico L; Sabbatini CE; Prévot-Monsacre P; Fourié T; Villarroel PMS; Priet S; Blanché H; Sebaoun JM; Deleuze JF; Turbelin C; Rossignol L; Werner A; Kochert F; Grosgogeat B; Rabiega P; Laupie J; Abraham N; Noël H; van der Werf S; Colizza V; Carrat F; Charrel R; de Lamballerie X; Blanchon T; Falchi A
    Sci Rep; 2024 Mar; 14(1):5418. PubMed ID: 38443618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nationwide Seroprevalence of SARS-CoV-2 IgG Antibodies among Four Groups of Primary Health-Care Workers and Their Household Contacts 6 Months after the Initiation of the COVID-19 Vaccination Campaign in France: SeroPRIM Study Protocol.
    Pouquet M; Decarreaux D; Prévot-Monsacré P; Hervé C; Werner A; Grosgogeat B; Blanché H; Rabiega P; Laupie J; Kochert F; Abraham N; Sebaoun JM; de Lamballerie X; Charrel R; Souty C; Camara I; Pergeline J; Noël H; Guerrisi C; Werf SV; Carrat F; Hanslik T; Blanchon T; Falchi A
    Pathogens; 2021 Jul; 10(7):. PubMed ID: 34358061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of SARS-CoV-2 antibodies in pediatric healthcare workers.
    Morris CR; Sullivan P; Mantus G; Sanchez T; Zlotorzynska M; Hanberry B; Iyer S; Heilman S; Camacho-Gonzalez A; Figueroa J; Manoranjithan S; Leake D; Mendis R; Cleeton R; Chen C; Krieger R; Bush P; Hughes T; Little WK; Suthar MS; Wrammert J; Vos MB
    Int J Infect Dis; 2021 Apr; 105():474-481. PubMed ID: 33722686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of SARS-CoV-2 IgG Antibodies and Factors Associated with SARS-CoV-2 IgG Neutralizing Activity among Primary Health Care Workers 6 Months after Vaccination Rollout in France.
    Decarreaux D; Pouquet M; Souty C; Vilcu AM; Prévot-Monsacre P; Fourié T; Villarroel PMS; Priet S; Blanché H; Sebaoun JM; Deleuze JF; Turbelin C; Werner A; Kochert F; Grosgogeat B; Rabiega P; Laupie J; Abraham N; Guerrisi C; Noël H; Van der Werf S; Carrat F; Hanslik T; Charrel R; De Lamballerie X; Blanchon T; Falchi A
    Viruses; 2022 May; 14(5):. PubMed ID: 35632699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.
    Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA
    Front Public Health; 2022; 10():967447. PubMed ID: 36276377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study.
    Carrat F; de Lamballerie X; Rahib D; Blanché H; Lapidus N; Artaud F; Kab S; Renuy A; Szabo de Edelenyi F; Meyer L; Lydié N; Charles MA; Ancel PY; Jusot F; Rouquette A; Priet S; Saba Villarroel PM; Fourié T; Lusivika-Nzinga C; Nicol J; Legot S; Druesne-Pecollo N; Esseddik Y; Lai C; Gagliolo JM; Deleuze JF; Bajos N; Severi G; Touvier M; Zins M;
    Int J Epidemiol; 2021 Nov; 50(5):1458-1472. PubMed ID: 34293141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceived risk and pandemic response awareness in low-capacity public primary health care in Greece.
    Gavana M; Papageorgiou DI; Haidich AB; Kokkali S; Talimtzi P; Paganas A; Andreou M; Yakimova-Polyzou V; Symintiridou D; Smyrnakis E
    Rural Remote Health; 2022 Jan; 22(1):6985. PubMed ID: 35077193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study.
    Murhekar MV; Bhatnagar T; Thangaraj JWV; Saravanakumar V; Santhosh Kumar M; Selvaraju S; Rade K; Kumar CPG; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chakraborty D; Chopra V; Das D; Devi KR; Dwivedi GR; Jain A; Khan SMS; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Ramesh T; Rangaraju C; Turuk J; Yadav S; Bhargava B;
    PLoS Med; 2021 Dec; 18(12):e1003877. PubMed ID: 34890407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Antibody Prevalence among Industrial Livestock Operation Workers and Nearby Community Residents, North Carolina, 2021 to 2022.
    Gigot C; Pisanic N; Kruczynski K; Gregory Rivera M; Spicer K; Kurowski KM; Randad P; Koehler K; Clarke WA; Holmes P; Hall DJ; Hall DJ; Heaney CD
    mSphere; 2023 Feb; 8(1):e0052222. PubMed ID: 36656002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of occupation for SARS-CoV-2 seroprevalence and COVID-19 vaccination among correctional workers in Quebec, Canada: A cross-sectional study.
    Kronfli N; Dussault C; Maheu-Giroux M; Halavrezos A; Chalifoux S; Park H; Balso LD; Cheng MP; Cox J
    Front Public Health; 2022; 10():1021871. PubMed ID: 36438247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and risk factors of SARS-CoV-2 infection among workers in a public health laboratory in Tunisia.
    Kharroubi G; Cherif I; Ghawar W; Dhaouadi N; Yazidi R; Chaabane S; Snoussi MA; Salem S; Ben Hammouda W; Ben Hammouda S; Gharbi A; Bel Haj Hmida N; Rourou S; Dellagi K; Barbouche MR; Benabdessalem C; Ben Ahmed M; Bettaieb J
    Arch Virol; 2023 Jan; 168(2):69. PubMed ID: 36658402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence, infection, and personal protective equipment use among Colombian healthcare workers during the COVID-19 pandemic.
    Beltrán EO; Martignon S; Coronel-Ruiz C; Velandia-Romero ML; Romero-Sanchez C; Avila V; Castellanos JE
    Front Public Health; 2023; 11():1225037. PubMed ID: 37900032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare workers highly affected during the COVID-19 epidemic wave in Poland prior to vaccination availability: seroprevalence study.
    Rosińska M; Stępień M; Kitowska W; Milczarek M; Juszczyk G; Nowacka Z; Gardel A; Hermann A; Bardoń-Błaszkowska A; Cudnik R; Czubak H; Wolniak-Bińkowska M; Źródłowska IA; Sadkowska-Todys M
    Med Pr; 2022 Apr; 73(2):109-123. PubMed ID: 35301511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Saliva-Based Serological and Behavioral Analysis of SARS-CoV-2 Antibody Prevalence in Howard County, Maryland.
    Brown AC; Koshute PT; Cowley HP; Robinette MS; Gravelyn SR; Patel SV; Ju EY; Frommer CT; Zambidis AE; Schneider EJ; Zhao MY; Mugo BK; Clarke W; Kruczynski K; Pisanic N; Heaney CD; Colella TA
    Microbiol Spectr; 2023 Aug; 11(4):e0276522. PubMed ID: 37289070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence, correlates and kinetics of SARS-CoV-2 nucleocapsid IgG antibody in healthcare workers and nonclinical staff at a tertiary hospital: A prevaccine census study.
    Maina D; Omuse G; Ong'ete G; Mugaine P; Sayed S; Moloo Z; Shah R; Etyang A; Adam R
    PLoS One; 2022; 17(10):e0267619. PubMed ID: 36301926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers.
    Bansal A; Trieu MC; Mohn KGI; Madsen A; Olofsson JS; Sandnes HH; Sævik M; Søyland H; Hansen L; Onyango TB; Tøndel C; Brokstad KA; ; Syre H; Riis ÅG; Langeland N; Cox RJ
    Front Public Health; 2023; 11():1164326. PubMed ID: 37546332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
    Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
    Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.